Results 21 to 30 of about 491,626 (323)

T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor?

Blood Advances, 2020
T-cell lymphoblastic lymphoma (T-LBL) and lymphoblastic leukemia (T-ALL) represent malignancies that arise from the transformation of immature precursor T cells.
E. Kroeze, J. Loeffen, V. M. Poort, J. Meijerink   +3 more
semanticscholar   +1 more source

Lymphoblastic Lymphoma of the Palate [PDF]

Baylor University Medical Center Proceedings, 2017
Lymphoblastic lymphomas are neoplasms of immature or precursor lymphoid cells with no or limited bone marrow involvement, whose clinical presentation varies according to the immunophenotype. While mediastinal involvement is predominant in T-lymphoblastic lymphomas, B-lymphoblastic lymphomas frequently involve nodal sites.
Rakul, Nambiar, Geetha, Narayanan, Lali V, Soman, Nandini, Devi   +3 more
openaire   +2 more sources

Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report

Pathology and Oncology Research, 2023
Objective: Indolent T-lymphoblastic proliferation (iT-LBP) is a non-neoplastic disease with an indolent clinical course, manifesting as hyperplasia of immature extrathymic T-lymphoblastic cells.
Wen Han, Bei Wang, Xiang Yong, Yi Zhang, Mingyu Shao, Chun Wang   +5 more
doaj   +1 more source

FIP1L1‐PDGFRA fusion gene in T‐lymphoblastic lymphoma: A case report

Cancer Reports, 2023
Background T‐lymphoblastic lymphoma (T‐LBL) is an aggressive malignancy of T‐lymphoid precursors, rarely co‐occurring with myeloid/lymphoid neoplasms with eosinophilia (M/LNs‐Eo), with consequent rearrangement of tyrosine kinase (TK)‐related genes.
Salhah Ali, Yasmine Al‐Qattan, Walaa Awny, Abdulaziz Hamadah, Karen Pinto, Salem AlShemmari   +5 more
doaj   +1 more source

BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T‐cell lymphoblastic lymphoma

Cancer Communications, 2020
Adult patients with T‐cell lymphoblastic lymphoma (T‐LBL) are treated with high‐intensity chemotherapy regimens, but the response rate is still unsatisfactory because of frequent drug resistance.
X. Tian, Jun Cai, Shuyun Ma, Yu Fang, Huiqiang Huang, Tongyu Lin, H. Rao, Mei Li, Z. Xia, Tiebang Kang, D. Xie, Q. Cai   +11 more
semanticscholar   +1 more source

CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia

Haematologica, 2019
The potential of CD123-targeted therapies in acute lymphoblastic leukemia/lymphoma remains largely unexplored. We examined CD123 expression levels in a large cohort of patients with acute lymphoblastic leukemia/lymphoma and assessed the in vitro impact ...
Evgeniya Angelova, Charlene Audette, Yelena Kovtun, Naval Daver, Sa A. Wang, Sherry Pierce, Sergej N. Konoplev, Haitham Khogeer, Jeffrey L. Jorgensen, Marina Konopleva, Patrick A. Zweidler-McKay, L. Jeffrey Medeiros, Hagop M. Kantarjian, Elias J. Jabbour, Joseph D. Khoury   +14 more
doaj   +1 more source

A case of systemic precursor T-cell lymphoblastic lymphoma presenting with single tooth mobility

SAGE Open Medical Case Reports, 2020
Lymphoblastic lymphoma, seen primarily in children or young adults, is a type of non-Hodgkin lymphoma that originates from B or T lymphocyte precursors and rarely occurs in the oral cavity.
Lampros Goutzanis, John Apostolidis, Chara Giatra, Evanthia Chrysomali, Dimitrios Deskos   +4 more
doaj   +1 more source

Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma.

Blood Advances, 2020
Tisagenlecleucel is a CD19 chimeric antigen receptor (CAR) T-cell therapy approved for treatment of pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia (ALL) and adults with non-Hodgkin lymphoma (NHL).
M. Pasquini, Zhen-Huan Hu, K. Curran, T. Laetsch, F. Locke, R. Rouce, M. Pulsipher, C. Phillips, A. Keating, M. Frigault, Dana B. Salzberg, S. Jaglowski, Joshua P. Sasine, J. Rosenthal, M. Ghosh, D. Landsburg, S. Margossian, P. Martin, M. Kamdar, P. Hematti, S. Nikiforow, C. Turtle, M. Perales, Patricia Steinert, M. Horowitz, A. Moskop, L. Pacaud, Lan Yi, Raghav Chawla, E. Bleickardt, S. Grupp   +30 more
semanticscholar   +1 more source

Primary breast non-Hodgkin’s lymphoma in a 14-year-old girl: a case report

Surgical Case Reports, 2020
Background Primary breast lymphoma is rare. Occurrence rates of malignant breast tumors in children are also quite low. We herein report a B-lymphoblastic lymphoma of the breast arisen in an adolescent girl.
Yumiko Ishizuka, Yoshiya Horimoto, Junya Fujimura, Kozue Ogata, Fumi Murakami, Hiroko Onagi, Atsushi Arakawa, Mitsue Saito   +7 more
doaj   +1 more source

A novel flow cytometric assay for detection of residual disease in patients with B‐lymphoblastic leukemia/lymphoma post anti‐CD19 therapy [PDF]

Cytometry. Part B, Clinical cytometry, 2016
Sindhu Cherian, Valerie Miller, Vivian McCullouch, Katy J. Dougherty, Jonathan R. Fromm, Brent L. Wood   +5 more
openalex   +2 more sources